Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc., formed through the business combination of blank-check company Mana Capital Acquisition Corp (Nasdaq: MAAQ) and Cardio Diagnostics, Inc., filed an 8-K current report with the SEC on May 30, 2023, bearing accession number 0001079973-23-000793. Mana Capital Acquisition Corp, sponsored by Mana Capital LLC, completed its IPO in 2021 and operated within the healthcare and life sciences sector, targeting companies in the diagnostics and medical technology space. The combined post-merger entity, Cardio Diagnostics Holdings, focuses on AI-powered cardiovascular disease diagnostics using epigenetic biomarker technology. For full filing details, sponsor disclosures, and ongoing deal tracking for this and hundreds of other SPACs, sign up for a SpacDesk account at spacdesk.com.